Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world.

Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform.

For more information please visit www.nicox.com

Health Care

Medical Devices

Therapeutics

Nicox

Adrienne L. Graves

Gavin Spencer

Doug Hubatsch

Donald Budenz

Robert D. Fechtner

Robert N. Weinreb

Steven L. Mansberger

Elizabeth Robinson

Emmet Purtill

Emma Pelletier

Thomas R. Walters

Sanjay G. Asrani

The Leadership Team at Nicox is responsible for guiding the company's strategic direction and fostering innovation in ophthalmic research and development. This team, composed of executives from diverse backgrounds, collaborates to oversee corporate development, clinical strategy, and scientific advancements, ensuring alignment with the company's growth objectives and commitment to delivering innovative therapeutic solutions for eyecare practitioners and patients worldwide.

Leadership Team

Clinical Development Team

Leadership Team

About

Team members

Other teams at Nicox

Clinical Development Team